Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis
Open Access
- 21 November 2001
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 1 (1) , 2
- https://doi.org/10.1186/1471-2466-1-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The action of antituberculosis drugs in short-course chemotherapyPublished by Elsevier ,2004
- Foreword from the Co-Editor-in-ChiefTuberculosis, 2001
- Modern methods for assessing the drugs used in the chemotherapy of mycobacterial diseaseJournal of Applied Microbiology, 1996
- Assessment of New Sterilizing Drugs for Treating Pulmonary Tuberculosis by Culture at 2 MonthsAmerican Review of Respiratory Disease, 1993
- A Toolkit for Testing for Non-Normality in Complete and Censored SamplesJournal of the Royal Statistical Society: Series D (The Statistician), 1993
- Understanding the chemotherapy of tuberculosis—current problemsJournal of Antimicrobial Chemotherapy, 1992
- Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: Final reportTubercle, 1986
- CONTROLLED CLINICAL TRIAL OF FOUR SHORT-COURSE (6-MONTH) REGIMENS OF CHEMOTHERAPY FOR TREATMENT OF PULMONARY TUBERCULOSIS Third ReportThe Lancet, 1974
- A Selective Oleic Acid Albumin Agar Medium For Tubercle BacilliJournal of Medical Microbiology, 1972
- THE FATE OF MYCOBACTERIUM TUBERCULOSIS IN MOUSE TISSUES AS DETERMINED BY THE MICROBIAL ENUMERATION TECHNIQUEThe Journal of Experimental Medicine, 1956